Personnel Information

写真a

SHIMADA Shu


Job title

Assistant Professor

Birth date

1979

Laboratory Address

Department of Molecular Oncology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan

Laboratory Phone number

+81-3-5803-5183

Laboratory Fax number

+81-3-5803-0125

Mail Address

shimada.monc@tmd.ac.jp

Campus Career 【 display / non-display

  • 2011.04
    -
    2011.09
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Advanced Therapeutic Sciences, Molecular Oncology, Project Assistant Professor
  • 2011.10
    -
    2018.03
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Advanced Therapeutic Sciences, Molecular Oncology, Assistant Professor
  • 2018.04
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Advanced Therapeutic Sciences, Molecular Oncology, Assistant Professor

External Career 【 display / non-display

  • 2005.04
    -
    2006.03
    , Senior Resident
  • 2006.04
    -
    2007.03
    , Senior Resident

Research Areas 【 display / non-display

  • Other

Qualification Acquired 【 display / non-display

  • Doctor

 

Published Papers & Misc 【 display / non-display

  • Seol HS, Akiyama Y, Lee SE, Shimada S, Jang SJ.. Loss of miR-100 and miR-125b results in cancer stem cell properties through IGF2 upregulation in hepatocellular carcinoma. Scientific Reports.. 2020.12; 10 (1): ( DOI )

  • Yoshino J, Akiyama Y, Shimada S, Ogura T, Ogawa K, Ono H, Mitsunori Y, Ban D, Kudo A, Yamaoka S, Tanabe M, Tanaka S. Loss of ARID1A induces a stemness gene ALDH1A1 expression with histone acetylation in the malignant subtype of cholangiocarcinoma. Carcinogenesis. 2020.07; 41 (6): 734-742. ( PubMed, DOI )

  • Fujita M, Yamaguchi R, Hasegawa T, Shimada S, Arihiro K, Hayashi S, Maejima K, Nakano K, Fujimoto A, Ono A, Aikata H, Ueno M, Hayami S, Tanaka H, Miyano S, Yamaue H, Chayama K, Kakimi K, Tanaka S, Imoto S, Nakagawa H. Classification of primary liver cancer with immunosuppression mechanisms and correlation with genomic alterations. EBioMedicine. 2020.03; 53 102659. ( PubMed, DOI )

  • Asakawa M, Itoh M, Suganami T, Sakai T, Kanai S, Shirakawa I, Yuan X, Hatayama T, Shimada S, Akiyama Y, Fujiu K, Inagaki Y, Manabe I, Yamaoka S, Yamada T, Tanaka S, Ogawa Y. Upregulation of cancer-associated gene expression in activated fibroblasts in a mouse model of non-alcoholic steatohepatitis. Scientific reports. 2019.12; 9 (1): 19601. ( PubMed, DOI )

  • Shimada S, Tanaka S. A new era for understanding genetic evolution of multistep carcinogenesis. Journal of gastroenterology. 2019.07; 54 (7): 667-668. ( PubMed, DOI )

display all >>

Conference Activities & Talks 【 display / non-display

  • Shuichi Watanabe, Shu Shimada, Jo NIshino, Kohei Yagi, Aya Maekawa, Yoshiki Murase, Toshitaka Sugawara, Takeshi Ishii, Tomotaka Kato, Masafumi Akasu, Yoshiya Ishikawa, Keiichi Akahoshi, Kosuke Ogawa, Hiroaki Ono, Daisuke Ban, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Estimation of the type of HCC metastasis based on the multicellular colonization model. The 32nd Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery 2021.02.23 Web

  • Shu Shimada, Yoshimitsu Akiyama, Shigeki Arii, Minoru Tanabe, Shinji Tanaka. Comprehensive molecular and immunological classification of hepatocellular carcinoma. The 56th Annual Meeting of Liver Cancer Study Group of Japan 2020.12.22 Online

  • Shimada S, Akiyama Y, Tanabe M, Tanaka S. Loss of KDM6A characterizes a poor prognostic subtype of pancreatic cancer and potentiates HDAC inhibitor lethali . The 79th Annual Meeting of the Japanese Cancer Association 2020.10.01 Yokohama, Online

  • Akiyama Y, Shimada S, Tanabe M, Tanaka S. Loss of ARID1A increases a stemness gene ALDH1A1 expression through histone acetylation change in cholangiocarcinoma.. The 79th Annual Meeting of the Japanese Cancer Association 2020.10.01 Yokohama, Online

  • Shimada S, Akiyama Y, Tanaka S. Loss of KDM6A characterizes a poor prognostic subtype of pancreatic cancer and potentiates HDAC inhibitor lethality . The 23rd Frontier Scientists Workshop, Post A3-2020 Symposium on Epigenetic Signature of Carcinogenesis 2020.09.19 Seoul, Korea, Online

display all >>